Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
 Disease Category: Diabetes Mellitus, Type 2
Location: United States, MO

Trial Information

A Multi-center, Randomized, Open-label, Active Controlled, Parallel Arm Study to Compare the Efficacy of 12 Weeks of Treatment with Vildagliptin 100mg, qd to Thiazolidinedione (TZD) as Add-on Therapy in Patients with type 2 Diabetes Inadequately Controlled with Metformin Monotherapy in a Community-based Practice Setting

This is a 12 week research study for males and females with type 2 diabetes inadequately controlled with metformin(glucophage) of at least 1000mg per day.

Patient Inclusion Criteria

  • Patient must be between the age of 18-80 years.
  • Patient must be on metformin (glucophage) of at least 1000mg per day.
  • HgbA1c in the range of 7-10.

Patient Exclusion Criteria

  • Patients must not have type 1 Diabetes
  • Patients must not have been on any other diabetic medication other than metformin in the last 8 weeks.
  • Patients must not have a history of a heart attack, coronary artery bypass surgery, or unstable angina in the last 6 months.
  • The patient must not have congestive heart failure that requires medication.
  • Patients must not have any liver disease.

For more information,

Patience Chambers, Study Coordinator/Director
Dynamic Clinical Research, Inc.
1010 Carondelet Drive, Suite 130
Kansas City, MO 64114
Phone: 816-942-2626
Fax: 816-942-2634
Email: patience.chambers@sbcglobal.net

View Map

Research Center Information: Dynamic Clinical Research, Inc.

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.